{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T08:49:29Z","timestamp":1768985369236,"version":"3.49.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejso.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology (EJSO)"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.ejso.2016.02.005","type":"journal-article","created":{"date-parts":[[2016,2,11]],"date-time":"2016-02-11T09:39:02Z","timestamp":1455183542000},"page":"672-678","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Clinical impact of breast MRI with regard to axillary reverse mapping in clinically node positive breast cancer patients following neo-adjuvant chemotherapy"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3740-225X","authenticated-orcid":false,"given":"M.A.","family":"Beek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Tetteroo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.J.T.","family":"Luiten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.D.","family":"Gobardhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.J.T.","family":"Rutten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.B.","family":"Heijns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.C.","family":"Voogd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.G.","family":"Klompenhouwer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.ejso.2016.02.005_bib1","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1056\/NEJMoa021967","article-title":"A\u00a0gene-expression signature as a predictor of survival in breast cancer","volume":"347","author":"van de Vijver","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"21","key":"10.1016\/j.ejso.2016.02.005_bib2","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1093\/jnci\/90.21.1601","article-title":"Meeting highlights: international consensus panel on the treatment of primary breast cancer","volume":"90","author":"Goldhirsch","year":"1998","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"8","key":"10.1016\/j.ejso.2016.02.005_bib3","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.ejso.2013.05.009","article-title":"Can axillary reverse mapping avoid lymphedema in node positive breast cancer patients?","volume":"39","author":"Tausch","year":"2013","journal-title":"Eur J Surg Oncol: J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2016.02.005_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12282-012-0416-4","article-title":"The changing role of axillary lymph node dissection for breast cancer","volume":"20","author":"Noguchi","year":"2013","journal-title":"Breast Cancer"},{"issue":"9","key":"10.1016\/j.ejso.2016.02.005_bib5","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1016\/j.ejca.2009.02.012","article-title":"Late morbidity associated with a tumour-negative sentinel lymph node biopsy in primary breast cancer patients: a systematic review","volume":"45","author":"Liu","year":"2009","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.ejso.2016.02.005_bib6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/BF02967068","article-title":"The role of axillary lymph node dissection in breast cancer management","volume":"4","author":"Noguchi","year":"1997","journal-title":"Breast Cancer"},{"issue":"7","key":"10.1016\/j.ejso.2016.02.005_bib7","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/jso.20905","article-title":"A\u00a0new concept toward the prevention of lymphedema: axillary reverse mapping","volume":"97","author":"Klimberg","year":"2008","journal-title":"J\u00a0Surg Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2016.02.005_bib8","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1245\/s10434-008-0030-z","article-title":"Combined axillary reverse mapping (ARM) technique for breast cancer patients requiring axillary dissection","volume":"15","author":"Nos","year":"2008","journal-title":"Ann Surg Oncol"},{"issue":"9","key":"10.1016\/j.ejso.2016.02.005_bib9","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1245\/s10434-007-9450-4","article-title":"Blue dye injection in the arm in order to conserve the lymphatic drainage of the arm in breast cancer patients requiring an axillary dissection","volume":"14","author":"Nos","year":"2007","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"10.1016\/j.ejso.2016.02.005_bib10","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1245\/s10434-007-9412-x","article-title":"Axillary reverse mapping (ARM): a new concept to identify and enhance lymphatic preservation","volume":"14","author":"Thompson","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2016.02.005_bib11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/1745-6215-14-111","article-title":"The clinical relevance of axillary reverse mapping (ARM): study protocol for a randomized controlled trial","volume":"14","author":"Klompenhouwer","year":"2013","journal-title":"Trials"},{"issue":"8","key":"10.1016\/j.ejso.2016.02.005_bib12","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.ejso.2012.04.012","article-title":"ARM: axillary reverse mapping \u2013 the need for selection of patients","volume":"38","author":"Gobardhan","year":"2012","journal-title":"Eur J Surg Oncol: J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2016.02.005_bib13","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejso.2014.09.012","article-title":"Axillary reverse mapping (ARM) in clinically node positive breast cancer patients","volume":"41","author":"Beek","year":"2015","journal-title":"Eur J Surg Oncol: J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2016.02.005_bib14","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/jso.22094","article-title":"Axillary reverse mapping using a fluorescence imaging system in breast cancer","volume":"105","author":"Noguchi","year":"2012","journal-title":"J\u00a0Surg Oncol"},{"issue":"12","key":"10.1016\/j.ejso.2016.02.005_bib15","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1007\/s00432-011-1064-3","article-title":"Safety study of axillary reverse mapping in the surgical treatment for breast cancer patients","volume":"137","author":"Deng","year":"2011","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2016.02.005_bib16","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1148\/radiol.11110639","article-title":"Accuracy of unenhanced MR imaging in the detection of axillary lymph node metastasis: study of reproducibility and reliability","volume":"262","author":"Scaranelo","year":"2012","journal-title":"Radiology"},{"issue":"7","key":"10.1016\/j.ejso.2016.02.005_bib17","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1245\/s10434-010-0934-2","article-title":"Can breast MRI predict axillary lymph node metastasis in women undergoing neoadjuvant chemotherapy","volume":"17","author":"Javid","year":"2010","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2016.02.005_bib18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/jmri.21802","article-title":"Magnetic resonance imaging for axillary staging in patients with breast cancer","volume":"30","author":"Mortellaro","year":"2009","journal-title":"J\u00a0Magn Reson Imaging JMRI"},{"issue":"9","key":"10.1016\/j.ejso.2016.02.005_bib19","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1007\/s003300000370","article-title":"Axillary lymph node metastases in breast cancer: preoperative detection with dynamic contrast-enhanced MRI","volume":"10","author":"Kvistad","year":"2000","journal-title":"Eur Radiol"},{"issue":"5","key":"10.1016\/j.ejso.2016.02.005_bib20","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2559.1991.tb00229.x","article-title":"Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up","volume":"19","author":"Elston","year":"1991","journal-title":"Histopathology"},{"key":"10.1016\/j.ejso.2016.02.005_bib21","unstructured":"NOABON. Landelijke richtlijn mammacarcinoom 2.0. www.oncolinenl\/mammacarcinoom."},{"issue":"1","key":"10.1016\/j.ejso.2016.02.005_bib22","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/ijc.28660","article-title":"High-level ERBB2 gene amplification is associated with a particularly short time-to-metastasis, but results in a high rate of complete response once trastuzumab-based therapy is offered in the metastatic setting","volume":"135","author":"Fuchs","year":"2014","journal-title":"Int J Cancer J Int du Cancer"},{"issue":"10","key":"10.1016\/j.ejso.2016.02.005_bib23","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1245\/s10434-012-2484-2","article-title":"The role for sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node-positive breast cancer","volume":"19","author":"Alvarado","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.ejso.2016.02.005_bib24","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.ejso.2011.05.012","article-title":"Accuracy of sentinel lymph node biopsy after neo-adjuvant chemotherapy in patients with locally advanced breast cancer and clinically positive axillary nodes","volume":"37","author":"Canavese","year":"2011","journal-title":"European J Surg Oncol: J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"issue":"4","key":"10.1016\/j.ejso.2016.02.005_bib25","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/SLA.0b013e3181b8fd5e","article-title":"Sentinel lymph node surgery after neoadjuvant chemotherapy is accurate and reduces the need for axillary dissection in breast cancer patients","volume":"250","author":"Hunt","year":"2009","journal-title":"Ann Surg"},{"issue":"5","key":"10.1016\/j.ejso.2016.02.005_bib26","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.acra.2009.01.026","article-title":"Breast cancer sentinel node identification and classification after neoadjuvant chemotherapy-systematic review and meta analysis","volume":"16","author":"Kelly","year":"2009","journal-title":"Acad Radiol"},{"issue":"18","key":"10.1016\/j.ejso.2016.02.005_bib27","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1016\/j.ejca.2009.08.001","article-title":"Accuracy of sentinel node biopsy after neoadjuvant chemotherapy in breast cancer patients: a systematic review","volume":"45","author":"van Deurzen","year":"2009","journal-title":"Eur J Cancer"},{"issue":"5","key":"10.1016\/j.ejso.2016.02.005_bib28","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/bjs.5209","article-title":"Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer","volume":"93","author":"Xing","year":"2006","journal-title":"Br J Surg"},{"issue":"1","key":"10.1016\/j.ejso.2016.02.005_bib29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/jso.23048","article-title":"Extensive nodal involvement increases the positivity of blue nodes in the axillary reverse mapping procedure in patients with breast cancer","volume":"106","author":"Rubio","year":"2012","journal-title":"J\u00a0Surg Oncol"},{"issue":"5","key":"10.1016\/j.ejso.2016.02.005_bib30","first-page":"421","article-title":"Axillary reverse mapping (ARM): initial results of phase II trial in preventing lymphedema after lymphadenectomy","volume":"64","author":"Boneti","year":"2012","journal-title":"Minerva Ginecol"},{"issue":"7","key":"10.1016\/j.ejso.2016.02.005_bib31","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.ejso.2014.03.023","article-title":"The influence of axillary reverse mapping related factors on lymphedema in breast cancer patients","volume":"40","author":"Ikeda","year":"2014","journal-title":"Eur J Surg Oncol: J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2016.02.005_bib32","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1245\/s10434-014-3626-5","article-title":"Prospective study evaluating oncological safety of axillary reverse mapping","volume":"21","author":"Schunemann","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ejso.2016.02.005_bib33","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/1477-7819-10-233","article-title":"Evaluation of the metastatic status of lymph nodes identified using axillary reverse mapping in breast cancer patients","volume":"10","author":"Ikeda","year":"2012","journal-title":"World J Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2016.02.005_bib34","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/jso.21473","article-title":"Axillary reverse mapping with indocyanine fluorescence imaging in patients with breast cancer","volume":"101","author":"Noguchi","year":"2010","journal-title":"J\u00a0Surg Oncol"},{"key":"10.1016\/j.ejso.2016.02.005_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.clbc.2015.01.010","article-title":"A\u00a0prospective study to Assess the feasibility of axillary reverse mapping and evaluate its effect on preventing lymphedema in breast cancer patients","author":"Yue","year":"2015","journal-title":"Clin Breast Cancer"},{"issue":"11","key":"10.1016\/j.ejso.2016.02.005_bib36","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1002\/cncr.25096","article-title":"A\u00a0phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patients","volume":"116","author":"Bedrosian","year":"2010","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.ejso.2016.02.005_bib37","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.acra.2014.10.010","article-title":"Suspicious axillary lymph nodes identified on clinical breast MRI in patients newly diagnosed with breast cancer: can quantitative features improve discrimination of malignant from benign?","volume":"22","author":"Rahbar","year":"2015","journal-title":"Acad Radiol"},{"issue":"2","key":"10.1016\/j.ejso.2016.02.005_bib38","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s13244-015-0404-2","article-title":"The role of MRI in axillary lymph node imaging in breast cancer patients: a systematic review","volume":"6","author":"Kuijs","year":"2015","journal-title":"Insights Imaging"},{"issue":"4","key":"10.1016\/j.ejso.2016.02.005_bib39","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3233\/BD-140371","article-title":"Axillary reverse mapping: is it feasible in locally advanced breast cancer patients?","volume":"34","author":"Khandelwal","year":"2014","journal-title":"Breast Dis"},{"issue":"11","key":"10.1016\/j.ejso.2016.02.005_bib40","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.acra.2013.08.003","article-title":"Accuracy of axillary lymph node staging in breast cancer patients: an observer-performance study comparison of MRI and ultrasound","volume":"20","author":"Abe","year":"2013","journal-title":"Acad Radiol"}],"container-title":["European Journal of Surgical Oncology (EJSO)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798316000998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798316000998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T08:57:56Z","timestamp":1718355476000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798316000998"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":40,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0748798316000998"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2016.02.005","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical impact of breast MRI with regard to axillary reverse mapping in clinically node positive breast cancer patients following neo-adjuvant chemotherapy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology (EJSO)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2016.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}